67877-550 : Deferasirox 250 mg Oral Tablet, for Suspension


NDC: 67877-550
Labeler: Ascend Laboratories, LLC
Product Type: Human Prescription Drug
Drug Name:  Deferasirox
Dosage Form: Oral Tablet, for Suspension
Application #: ANDA210519
Rev. Date: 


Appearance:


Markings: DS;250
Shapes:  Round
Colors:  White
Size (mm): 15
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 67877-550-30: 30 TABLET, FOR SUSPENSION IN 1 BOTTLE (67877‑550‑30)

Active Ingredients:

  • Deferasirox

Dosage Strength:

  • 250 mg

Inactive Ingredients:

  • Microcrystalline Cellulose 102
  • Crospovidone (120 .mu.m)
  • Low-substituted Hydroxypropyl Cellulose, Unspecified
  • Silicon Dioxide
  • Hypromellose 2910 (5 Mpa.s)
  • Sodium Lauryl Sulfate
  • Sodium Phosphate, Dibasic, Anhydrous
  • Hydrogenated Castor Oil
  • Magnesium Stearate /

Pharmaceutical Classes:

  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 67877-549 Deferasirox 125 mg Oral Tablet, for Suspension by Ascend Laboratories, LLC
  • 67877-551 Deferasirox 500 mg Oral Tablet, for Suspension by Ascend Laboratories, LLC
  • 67877-552 Deferasirox 90 mg Oral Tablet, Film Coated by Ascend Laboratories, LLC
  • 67877-553 Deferasirox 180 mg Oral Tablet, Film Coated by Ascend Laboratories, LLC
  • 67877-554 Deferasirox 360 mg Oral Tablet, Film Coated by Ascend Laboratories, LLC
  • 0093-3515 Deferasirox 360 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0093-3516 Deferasirox 180 mg Oral Tablet, Film Coated by Teva Pharmaceuticals USA, Inc.
  • 0093-3517 Deferasirox 90 mg Oral Tablet by Teva Pharmaceuticals USA, Inc.
  • 0591-3853 Deferasirox 180 mg Oral Tablet, Film Coated by Actavis Pharma, Inc.
  • 0591-4730 Deferasirox 90 mg Oral Granule by Actavis Pharma, Inc.
  • 0591-4735 Deferasirox 180 mg Oral Granule by Actavis Pharma, Inc.
  • 0591-4740 Deferasirox 360 mg Oral Granule by Actavis Pharma, Inc.
  • 16714-993 Deferasirox 90 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-994 Deferasirox 180 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 16714-995 Deferasirox 360 mg Oral Tablet, Film Coated by Northstar Rx LLC.
  • 31722-011 Deferasirox 90 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-012 Deferasirox 180 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-013 Deferasirox 360 mg Oral Tablet, Film Coated by Camber Pharmaceuticals, Inc.
  • 31722-029 Deferasirox 90 mg Oral Granule by Camber Pharmaceuticals, Inc.
  • 31722-030 Deferasirox 180 mg Oral Granule by Camber Pharmaceuticals, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 67877-550 QR Code

< Prev: 67877-549Next: 67877-551 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.